Works by Mahipal, Amit

Results: 87
    1
    2
    3
    4
    5

    Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.

    Published in:
    Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
    By:
    • Tella, Sri Harsha;
    • Foster, Nathan;
    • Qian, Shi;
    • Nguyen, Tran;
    • Borad, Mitesh J;
    • McWilliams, Robert R;
    • Alberts, Steven R;
    • Ma, Wen Wee;
    • Chakrabarti, Sakti;
    • Fruth, Briant;
    • Wessling, Jaclynn;
    • Hartgers, Mindy;
    • Washburn, Leslie;
    • Fernandez-Zapico, Martin E;
    • Hogenson, Tara L;
    • Pitot, Henry;
    • Jin, Zhaohui;
    • Mahipal, Amit
    Publication type:
    Article
    6

    Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.

    Published in:
    Oncologist, 2023, v. 28, n. 6, p. 510, doi. 10.1093/oncolo/oyad009
    By:
    • Perera, Nirosha D;
    • Bellomo, Tiffany R;
    • Schmidt, Walker M;
    • Litt, Henry K;
    • Shyu, Margaret;
    • Stavins, MaKenna A;
    • Wang, Max M;
    • Bell, Alexander;
    • Saleki, Massoud;
    • Wolf, Katherine I;
    • Ionescu, Ruxandra;
    • Tao, Jacqueline J;
    • Ji, Sunjong;
    • O'Keefe, Ryan M;
    • Pun, Matthew;
    • Takasugi, Jordan M;
    • Steinberg, Jecca R;
    • Go, Ronald S;
    • Turner, Brandon E;
    • Mahipal, Amit
    Publication type:
    Article
    7
    8
    9
    10

    Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 7, p. 4413, doi. 10.1245/s10434-024-15187-y
    By:
    • Sugumar, Kavin;
    • Stitzel, Henry;
    • Wu, Victoria;
    • Bajor, David;
    • Chakrabarti, Sakti;
    • Conces, Madison;
    • Henke, Lauren;
    • Lumish, Melissa;
    • Mahipal, Amit;
    • Mohamed, Amr;
    • Winter, Jordan M.;
    • Hardacre, Jeffrey M.;
    • Ammori, John B.;
    • Selfridge, Jennifer E.;
    • Ocuin, Lee M.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18

    Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.651119
    By:
    • Kowalchuk, Roman O.;
    • Lester, Scott C.;
    • Graham, Rondell P.;
    • Harmsen, William S.;
    • Zhang, Lizhi;
    • Halfdanarson, Thorvardur R.;
    • Smoot, Rory L.;
    • Gits, Hunter C.;
    • Ma, Wen Wee;
    • Owen, Dawn;
    • Mahipal, Amit;
    • Miller, Robert C.;
    • Wittich, Michelle A. Neben;
    • Cleary, Sean P.;
    • McWilliams, Robert R.;
    • Haddock, Michael G.;
    • Hallemeier, Christopher L.;
    • Truty, Mark J.;
    • Merrell, Kenneth W.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Effect of Age on Clinical Outcomes in Phase 1 Trial Participants.

    Published in:
    Cancer Control: Journal of the Moffitt Cancer Center, 2015, v. 22, n. 2, p. 235, doi. 10.1177/107327481502200217
    By:
    • Mahipal, Amit;
    • Denson, Aaron C.;
    • Djulbegovic, Benjamin;
    • Lush, Richard;
    • Kumar, Ambuj;
    • Tzu-Hua Juan;
    • Schell, Michael J.;
    • Sullivan, Daniel M.
    Publication type:
    Article
    36

    Aspirin and Statin Use and the Risk of Gallbladder Cancer.

    Published in:
    Cancers, 2021, v. 13, n. 5, p. 1186, doi. 10.3390/cancers13051186
    By:
    • Prasai, Kritika;
    • Tella, Sri Harsha;
    • Yadav, Siddhartha;
    • Kommalapati, Anuhya;
    • Mara, Kristin;
    • Mady, Mohamed;
    • Hassan, Mohamed A.;
    • Wongjarupong, Nicha;
    • Rodriguez-Payan, Natalia;
    • Borad, Mitesh;
    • Patel, Tushar;
    • Roberts, Lewis R.;
    • Mahipal, Amit;
    • Rimassa, Lorenza
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.

    Published in:
    Digestive Diseases & Sciences, 2022, v. 67, n. 8, p. 3797, doi. 10.1007/s10620-021-07303-9
    By:
    • Uson Junior, Pedro Luiz Serrano;
    • DeLeon, Thomas T.;
    • Bogenberger, James M.;
    • Pai, Rish K.;
    • Kosiorek, Heidi E.;
    • Yin, Jun;
    • Ahn, Daniel H.;
    • Sonbol, Mohammad Bassam;
    • Bekaii-Saab, Tanios;
    • Mansfield, Aaron S.;
    • Buetow, Kenneth;
    • Gores, Gregory J.;
    • Smoot, Rory;
    • Vasmatzis, George;
    • Kipp, Benjamin R.;
    • Mahipal, Amit;
    • Baker, Alexander T.;
    • Babiker, Hani;
    • Barro, Oumar;
    • Dumbauld, Chelsae
    Publication type:
    Article
    45
    46

    A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
    By:
    • Ahn, Daniel H.;
    • Uson Junior, Pedro Luiz Serrano;
    • Masci, Peter;
    • Kosiorek, Heidi;
    • Halfdanarson, Thorvardur R.;
    • Mody, Kabir;
    • Babiker, Hani;
    • DeLeon, Thomas;
    • Sonbol, Mohamad Bassam;
    • Gores, Gregory;
    • Smoot, Rory;
    • Bekaii-Saab, Tanios;
    • Mahipal, Amit;
    • Mansfield, Aaron;
    • Tran, Nguyen H.;
    • Hubbard, Joleen M.;
    • Borad, Mitesh J.
    Publication type:
    Article
    47
    48
    49
    50